Analysing meningitis genes to identify new treatments

April 19, 2013, University of Liverpool
Analysing meningitis genes to identify new treatments

Scientists at the University of Liverpool are working to identify genes involved in the development of bacterial meningitis to support the search for new vaccine candidates.

Meningitis caused by is the most common in the UK and despite antibiotic treatment, morbidity and mortality still remains high, carrying a 30% chance of death.

Targeting bacterial genes

Scientists at Liverpool, supported by Meningitis UK, are using advanced bioinformatics and infection biology tools to identify the bacterial meningitis genes and their products associated with disease so that they can be targeted for new treatments and vaccines.

Combining world leading expertise in the field of genomics, proteomics and infection biology, the team will identify the essential genes involved in the development of meningitis and will relate products to phenotypic function so that they can be targeted for therapeutics or as potential vaccine candidates.
Professor Aras Kadioglu, from the University's Institute of Infection and Global Health, said: "Meningitis is a growing problem in the UK, and although the current protein is very effective, it only protects against 13 out of 90 different pneumococcal types.

Cross protection

"One issue with this is that we are seeing something called serotype replacement, which means that non-vaccine covered types are causing disease.

"It is unlikely that we will have a conjugate vaccine that will protect against all types, so the way forward is to develop novel therapeutics against pneumococcal that play a major role in the development of meningitis and to identify bacterial proteins as new vaccine candidates that will offer cross protection against all meningitis causing types."

Explore further: A new strategy for developing meningitis vaccines

Related Stories

A new strategy for developing meningitis vaccines

May 24, 2012
Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain. Children, elderly patients and immunocompromised patients are at a higher risk for the development of severe ...

EU drug regulator OKs Novartis' meningitis B shot

November 16, 2012
Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG.

Bridging the gap: Hope that all Meningitis strains will be vaccinated for

February 27, 2013
Scientists at the University of Southampton have taken a significant and important step in keeping people safe from the most common form of meningitis in the UK.

Recommended for you

Novel molecular target to prevent scarring of the lung blood vessels identified

June 13, 2018
Pulmonary arterial hypertension, a severe form of cardiopulmonary disease in which the arteries that transport blood from the heart to the lungs become thickened, constricted, and scarred, is a disease for which there is ...

Fast-acting cholera vaccine could curb outbreaks

June 13, 2018
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest. The rapid protection offered by this designer vaccine may one day limit the spread of cholera outbreaks, ...

Lineage of TB traced and compared to early human migration

June 13, 2018
A team of researchers from the University of Wisconsin, the University of Iowa and the Norwegian Institute of Public Health has carried out genetic studies of tuberculosis to learn more about its lineage and to compare it ...

Finally, hope for a syphilis vaccine

June 12, 2018
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers ...

How to slow down Ebola—Virologists use 'genetic trees' to evaluate intervention strategies

June 12, 2018
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just reveal how the Ebola virus was able to evolve—it also reveals which events and preventive measures accelerated or slowed down its spread. These findings ...

Small children and pregnant women may be underdosed in current malaria regimen

June 12, 2018
Current recommended dosing regimens for the most widely used treatment for uncomplicated Plasmodium falciparum malaria may be sub-optimal for the most vulnerable populations of patients, according to a study published this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.